TailorMed, a NYC-based healthcare technology company, raised $40M in funding combining equity and debt.
The round was led by Windham Capital Partners alongside Citi Impact Fund, Samsung Next, and BrightEdge, and the investment arms of some of the nation’s top health systems: Providence Ventures, OSF Healthcare, Inception Health, Ballad Ventures, UH Ventures, and UnityPoint Health Ventures. Other investors included Sanara Ventures, Triventures, Accelmed, Almeda Ventures, and Bridges. The debt facility was led by Poalim-tech, part of Israel’s leading bank, Bank HaPoalim.
The company intends to use the funds to grow across the United States.
Led by CEO Srulik Dvorsky, TailorMed is a provider of a comprehensive, end-to-end platform designed to eliminate barriers along the entire medication journey, from affordability to access and adherence. It is building a new category in healthcare, transforming how stakeholders—patients, providers, pharmacies, life sciences, and payers—work together to ensure that every patient, across all medical conditions, can receive the treatment they need without delay. Its enterprise solution manages the full lifecycle of patient support programs, reducing the cost of care and driving better outcomes.
Thanks to its partnerships with life sciences, TailorMed creates automation through direct integration with manufacturer assistance programs.
FinSMEs
22/11/2024